Gilead Sciences is a large biopharmaceutical company that discovers, develops, and sells medicines, especially for infectious diseases. According to filings, it lobbies on HIV prevention and procurement, drug pricing and reimbursement rules from the Inflation Reduction Act, Medicare and Medicaid matters, international trade and intellectual property protections for COVID-19 treatments, and global supply chain issues. It reports using the Tiber Creek Group for lobbying.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
COREY MALMGREN
The latest disclosures for this client.
TIBER CREEK GROUP
Q1TIBER CREEK GROUP
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
TIBER CREEK GROUP
JENNIFER OLSON
TIBER CREEK GROUP
JOHN MICHAEL GONZALEZ
TIBER CREEK GROUP
JONATHON JONES
TIBER CREEK GROUP
MATTHEW LEFFINGWELL
TIBER CREEK GROUP
NIKOLE BURROUGHS
TIBER CREEK GROUP
BRYANT HALL
TIBER CREEK GROUP
TIBER CREEK GROUP
Q3TIBER CREEK GROUP
Q2TIBER CREEK GROUP
Q1